Clinical trial
Trivalent, Live, Cold Adapted Influenza Vaccine (CAIV-T) Against Inactivated…
NCT00128167 · MedImmune LLC, Industry · Completed
Key facts
| NCT number | NCT00128167 |
|---|---|
| Title | Trivalent, Live, Cold Adapted Influenza Vaccine (CAIV-T) Against Inactivated Influenza Vaccine (TIV) in Children 6-59 Months of Age |
| Official title | A Randomized, Double-Blind Trial to Assess the Safety and Relative Efficacy of CAIV-T Against Inactivated Influenza Vaccine in Children 6-59 Months of Age |
| Lead sponsor | MedImmune LLC, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Influenza |
| Intervention type | Drug |
| Interventions | Liquid CAIV-T |
| Enrollment | 8,500 |
| Start date | Oct 1, 2004 |
| Completion | Dec 1, 2005 |
| First posted | Aug 9, 2005 |
| Last update posted | Sep 13, 2021 |
| Countries | Belgium, Czechia, Hong Kong, Ireland, South Korea, Taiwan, United Kingdom, United States |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: